ETGLX
Price
$62.13
Change
-$0.02 (-0.03%)
Updated
Jun 2 closing price
Net Assets
3.23B
PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

ETGLX vs PMBCX

Header iconETGLX vs PMBCX Comparison
Open Charts ETGLX vs PMBCXBanner chart's image
ETGLX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
ETGLX vs. PMBCX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETGLX is a Buy and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. ETGLX (3.23B). ETGLX (0.00) and PMBCX (0.00) have matching dividends . ETGLX was incepted earlier than PMBCX: ETGLX (18 years) vs PMBCX (19 years). PMBCX (1.71) is less costly to investors than ETGLX (1.38). ETGLX is a more actively managed with annual turnover of: 60.00 vs. PMBCX (13.70). ETGLX (1000) and PMBCX (1000) have matching initial minimum investment requirements. ETGLX annual gain was more profitable for investors over the last year : 20.61 vs. PMBCX (-15.11). ETGLX return over 5 years is better than : -2.83 vs. PMBCX (-9.16).
ETGLXPMBCXETGLX / PMBCX
Total Expense Ratio1.381.7181%
Annual Report Gross Expense Ratio1.381.7181%
Fund Existence18 years19 years-
Gain YTD13.807-7.252-190%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets3.23B24.6B13%
Annual Yield % from dividends0.000.00-
Returns for 1 year20.61-15.11-136%
Returns for 3 years35.469.97356%
Returns for 5 years-2.83-9.1631%
Returns for 10 years155.7653.20293%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COCH0.70N/A
+0.71%
Envoy Medical
SMWB4.380.03
+0.69%
Similarweb Ltd
FULTP18.490.01
+0.05%
Fulton Financial Corp
CTRE38.73-0.61
-1.55%
CareTrust REIT
NVCR15.81-0.75
-4.53%
NovoCure Limited